SLC6A3 and Parkinson disease: Early timepoints (7 and 14 days) did not reveal significant changes in behavioural performance, expression of PD-related markers (TH, DAT, α-synuclein), or oxidative stress indicators, including Nrf2, NOX2, malondialdehyde (MDA) and nitrate/nitrite levels.